Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Analysis of Laboratory Markers for Severe COVID-19

  • Read more about Analysis of Laboratory Markers for Severe COVID-19

Effects of m-CIMT With and Without Kinesiotaping for Children With Erb's Palsy

  • Read more about Effects of m-CIMT With and Without Kinesiotaping for Children With Erb's Palsy

Endothelial Dysfunction in Post-infection Fatigue Syndromes

  • Read more about Endothelial Dysfunction in Post-infection Fatigue Syndromes

Fat Oxidation Capacity in Patients With Post Covid-19 Syndrome

  • Read more about Fat Oxidation Capacity in Patients With Post Covid-19 Syndrome

2-year Mortality After COVID-19 in Nursing Home Residents

  • Read more about 2-year Mortality After COVID-19 in Nursing Home Residents

Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19

  • Read more about Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Severe COVID-19

Socioeconomic Behavior Changes During the Pandemic

  • Read more about Socioeconomic Behavior Changes During the Pandemic

M-TAPA vs Intraperitoneal Bupivacain vs Intraperitoneal Bupivacain +Dexmedetomidin

  • Read more about M-TAPA vs Intraperitoneal Bupivacain vs Intraperitoneal Bupivacain +Dexmedetomidin

Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds

  • Read more about Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds

Evaluation of the Safety and Performance Characteristics of Mesofiller Aox for the Correction of Mild and Moderate Facial Wrinkles.

  • Read more about Evaluation of the Safety and Performance Characteristics of Mesofiller Aox for the Correction of Mild and Moderate Facial Wrinkles.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Current page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA